Tesamorelin

Mechanism: Tesamorelin binds to pituitary somatotropes to trigger clean growth hormone spikes, downregulating lipid accumulation inside deep visceral adipose tissue pools.

Sequence: Trans-3-hexenoyl-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL

Recommended Dosage: Rigid dosing requirement: 1mg to 2mg administered subcutaneously 5 days per week. Must be deployed during a fasted state before bed.

Tracking Cycle: Evaluated over extended 12 to 24-week intervals to accurately trace reductions in deep visceral fat layers.